Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia

Preventing relapse after chemotherapy remains a challenge in acute myeloid leukemia (AML). Eighty-four non-transplanted AML patients in first complete remission received relapse-preventive immunotherapy with histamine dihydrochloride and low-dose interleukin-2 in an international phase IV trial (Cli...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Sander, Frida Ewald, Rydström, Anna, Bernson, Elin, Kiffin, Roberta, Riise, Rebecca, Aurelius, Johan, Anderson, Harald, Brune, Mats, Foà, Robin, Hellstrand, Kristoffer, Thorén, Fredrik B., Martner, Anna
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper: Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884940/
https://ncbi.nlm.nih.gov/pubmed/26863635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7210
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller